Flecainide Acetate

CHEMBL1200822 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
474.4 g/mol
LogP
Phase
4

This acetate salt form of flecainide is used to treat certain heart rhythm disorders, including atrial fibrillation and paroxysmal supraventricular tachycardia, by slowing electrical conduction in the heart. Regular monitoring of heart rhythm and drug levels is typically required during treatment.

Moleküler Ağırlık

474,4000 g/mol

TPSA

96,90 Ų

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)O.O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F

InChI

InChI=1S/C17H20F6N2O3.C2H4O2/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11;1-2(3)4/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26);1H3,(H,3,4)

Molecular Formula

C19H24F6N2O5

HBD / HBA

3 / 12

Döndürülebilir Bağlar

7

Ağır Atomlar

32

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This acetate salt form of flecainide is used to treat certain heart rhythm disorders, including atrial fibrillation and paroxysmal supraventricular tachycardia, by slowing electrical conduction in the heart. Regular monitoring of heart rhythm and drug levels is typically required during treatment.

Yes, Flecainide Acetate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200822. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 41022. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.